Showing results (51-60 of 452) with videos related to
Sort By:
Pageof 46
Current Radiopharmaceuticals|May 31, 2012
Scandium-44: benefits of a long-lived PET radionuclide available from the (44)Ti/(44)Sc generator systemF RoeschCurrent Radiopharmaceuticals|May 31, 2012
Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopesAlfred Morgenstern, Frank Bruchertseifer, Christos ApostolidisCurrent Radiopharmaceuticals|May 31, 2012
Future of low specific activity molybdenum-99/technetium-99m generatorA MushtaqCurrent Radiopharmaceuticals|May 23, 2019
68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different TracersFerdinando Calabria, Robert Pichler, Mario Leporace, et al.Current Radiopharmaceuticals|May 11, 2022
Evaluation of the Effect of Chelating Arms and Carrier Agents on t he Radiotoxicity of TAT AgentsSoghra Farzipour, Zahra Shaghaghi, Marziyeh Raeispour, et al.Current Radiopharmaceuticals|March 16, 2015
Theranostic Applications of Lutetium-177 in Radionuclide TherapyTapas Das, Sharmila BanerjeeCurrent Radiopharmaceuticals|March 16, 2015
Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal AntibodyShankar Vallabhajosula, Anastasia Nikolopoulou, Yuliya S Jhanwar, et al.Current Radiopharmaceuticals|March 16, 2015
Overview of Development and Formulation of ¹⁷⁷Lu-DOTA-TATE for PRRTWouter A P Breeman, Ho Sze Chan, Rory M S de Zanger, et al.Current Radiopharmaceuticals|March 16, 2015
Production of No-Carrier Added Lutetium-177 by Irradiation of Enriched Ytterbium-176Valery A Tarasov, Oleg I Andreev, Evgeny G Romanov, et al.Current Radiopharmaceuticals|March 16, 2015
Evolving Important Role of Lutetium-177 for Therapeutic Nuclear MedicineAmbikalmajan M R Pillai, Furn F Russ KnappPageof 46